biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by higgsbosonon Aug 03, 2016 7:01pm

129 Views

Post# 25108211

bolony and jerky

or should that be jerks
dont you guys ever get tired
you go to bed late at night and you get up early in the morning to post bolony sandwiches (bs)
and you fool yourelf and others with the allusion you are contributing to this board
there is a guy in calgary that is waiting and reading your every word; what a fool
give up already and wait to post or comment on something new with this company
that will take some time
and a lot fewer posts
ok now back on ignore

Bullboard Posts

Eminent acquires promising Nevada gold project